RE:RE:RE:RE:RE:RE:The paradox:With respect to Bioasis not hiring a research/clinical oncologist, would it be wise to do so? God bless Mark Day and all who sail upon him but if the Bioasis pipeline elements are there to attract partnerships (collaborations) then I suspect that such partners would have a BJT (big jeezely team) of oncologists, clinical trial experts, neuro-everythings, janitors, saw sharpeners and a host of superfluous executives to guide xB3 through every minefield it encounters.
It's never wise to limit ones horizons to old quotes, departed souls and < Ctrl-C >.
Fact is, we have no idea how many oncologists are at work on this now, or will be in the future.
jdstox